Biplab K Saha: Updating the Clinical Approach to IPH
Biplab K Saha, Associate Professor of Medicine at Indiana University Health, shared a post on LinkedIn:
“I am excited to share that the UpToDate topic on idiopathic pulmonary hemosiderosis (IPH) has been updated.
I had the privilege of co-authoring the topic with Nils Thorm Milman, who has been a mentor to me over the years.
IPH is a rare cause of recurrent diffuse alveolar hemorrhage affecting patients of any age but more common in children.
It is a diagnosis of exclusion and the accurate diagnosis is often delayed.
Recurrent bleeding can lead to pulmonary fibrosis and development of end stage lung disease requiring lung transplantation.
The chapter reviews clinical features, treatment, and prognosis.
I am truly grateful for the collaboration and the opportunity to keep this resource current for clinicians who encounter this uncommon disease throughout the world.”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience